Benjamin R - Search Results

1

Targeted morphoproteomic profiling of Ewing's sarcoma treated with insulin-like growth factor 1 receptor (IGF1R) inhibitors: response/resistance signatures.

Subbiah V, Naing A, Brown RE, Chen H, Doyle L, LoRusso P, Benjamin R, Anderson P, Kurzrock R. Subbiah V, et al. Among authors: benjamin r. PLoS One. 2011 Apr 6;6(4):e18424. doi: 10.1371/journal.pone.0018424. PLoS One. 2011. PMID: 21494688 Free PMC article.

2

Risks and benefits of phase 1 oncology trials, revisited.

Kurzrock R, Benjamin RS. Kurzrock R, et al. Among authors: benjamin rs. N Engl J Med. 2005 Mar 3;352(9):930-2. doi: 10.1056/NEJMe058007. N Engl J Med. 2005. PMID: 15745986 No abstract available.

3

Measuring drug response in sarcoma.

Benjamin R. Benjamin R. Clin Adv Hematol Oncol. 2006 Jul;4(7):513-4. Clin Adv Hematol Oncol. 2006. PMID: 17147238 No abstract available.

4

Chemotherapy response is an important predictor of local recurrence in Ewing sarcoma.

Lin PP, Jaffe N, Herzog CE, Costelloe CM, Deavers MT, Kelly JS, Patel SR, Madewell JE, Lewis VO, Cannon CP, Benjamin RS, Yasko AW. Lin PP, et al. Among authors: benjamin rs. Cancer. 2007 Feb 1;109(3):603-11. doi: 10.1002/cncr.22412. Cancer. 2007. PMID: 17177205 Free article.

5

Of mice and men: divergent risks of teriparatide-induced osteosarcoma.

Subbiah V, Madsen VS, Raymond AK, Benjamin RS, Ludwig JA. Subbiah V, et al. Among authors: benjamin rs. Osteoporos Int. 2010 Jun;21(6):1041-5. doi: 10.1007/s00198-009-1004-0. Epub 2009 Jul 14. Osteoporos Int. 2010. PMID: 19597911

6

Neoadjuvant treatment of soft-tissue sarcoma: a multimodality approach.

Reynoso D, Subbiah V, Trent JC, Guadagnolo BA, Lazar AJ, Benjamin R, Pollock RE, Ludwig JA. Reynoso D, et al. Among authors: benjamin r. J Surg Oncol. 2010 Mar 15;101(4):327-33. doi: 10.1002/jso.21481. J Surg Oncol. 2010. PMID: 20187067 Review.

7

A phase I study of weekly R1507, a human monoclonal antibody insulin-like growth factor-I receptor antagonist, in patients with advanced solid tumors.

Kurzrock R, Patnaik A, Aisner J, Warren T, Leong S, Benjamin R, Eckhardt SG, Eid JE, Greig G, Habben K, McCarthy CD, Gore L. Kurzrock R, et al. Among authors: benjamin r. Clin Cancer Res. 2010 Apr 15;16(8):2458-65. doi: 10.1158/1078-0432.CCR-09-3220. Epub 2010 Apr 6. Clin Cancer Res. 2010. PMID: 20371689 Clinical Trial.

8

Insulin growth factor-receptor (IGF-1R) antibody cixutumumab combined with the mTOR inhibitor temsirolimus in patients with refractory Ewing's sarcoma family tumors.

Naing A, LoRusso P, Fu S, Hong DS, Anderson P, Benjamin RS, Ludwig J, Chen HX, Doyle LA, Kurzrock R. Naing A, et al. Among authors: benjamin rs. Clin Cancer Res. 2012 May 1;18(9):2625-31. doi: 10.1158/1078-0432.CCR-12-0061. Epub 2012 Mar 31. Clin Cancer Res. 2012. PMID: 22465830 Free PMC article. Clinical Trial.

9

Germline PTPRD mutations in Ewing sarcoma: biologic and clinical implications.

Jiang Y, Janku F, Subbiah V, Angelo LS, Naing A, Anderson PM, Herzog CE, Fu S, Benjamin RS, Kurzrock R. Jiang Y, et al. Among authors: benjamin rs. Oncotarget. 2013 Jun;4(6):884-9. doi: 10.18632/oncotarget.1021. Oncotarget. 2013. PMID: 23800680 Free PMC article.

10

Dual targeting of the insulin-like growth factor and collateral pathways in cancer: combating drug resistance.

Ludwig JA, Lamhamedi-Cherradi SE, Lee HY, Naing A, Benjamin R. Ludwig JA, et al. Among authors: benjamin r. Cancers (Basel). 2011 Jul 26;3(3):3029-54. doi: 10.3390/cancers3033029. Cancers (Basel). 2011. PMID: 24212944 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,038 results

Search Page